Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
超級聯賽企業和其他2只股票在$2以下，內部人士正在購買
The Dow Jones index closed lower by over 500 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週三收盤下跌超過500點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是細價股最近幾筆值得注意的內幕交易。欲了解更多信息，請訪問Benzinga的內幕交易平台。
Super League Enterprise
超級聯賽企業版
- The Trade: Super League Enterprise, Inc. (NASDAQ:SLE) Director Jeff Patrick Gehl bought a total of 50,000 shares at an average price of $1.35. To acquire these shares, it cost around $67,548.
- What's Happening: On June 21, Super League issued a mid-year update from the Company's Chief Executive Office, Ann Hand.
- What Super League Enterprise Does: Super League Enterprise Inc is the rocket ship to the metaverse.
- 貿易：超級聯盟企業公司（納斯達克股票代碼：SLE）董事傑夫·帕特里克·蓋爾以1.35美元的平均價格共購買了5萬股股票。收購這些股票的成本約爲67,548美元。
- 發生了什麼：6月21日，超級聯賽發佈了公司首席執行官安·漢德的年中最新消息。
- 超級聯盟企業是做什麼的：超級聯盟企業公司是通往元宇宙的火箭飛船。
aTyr Pharma
aTyr 製藥
- The Trade: aTyr Pharma, Inc. (NASDAQ:ATYR) Director Paul Schimmel acquired a total of 100,000 shares at an average price of $1.85. To acquire these shares, it cost around $184,613.
- What's Happening: On July 22, HC Wainwright & Co. analyst Joseph Pantginis reiterated aTyr Pharma with a Buy rating and maintained a $35 price target.
- What aTyr Pharma Does: aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform.
- 交易：aTyr Pharma, Inc.（納斯達克股票代碼：ATYR）董事保羅·席梅爾共收購了10萬股股票，平均價格爲1.85美元。收購這些股票的成本約爲184,613美元。
- 發生了什麼：7月22日，HC Wainwright & Co. 分析師約瑟夫·潘特吉尼斯重申了AtyR Pharma的買入評級，並維持了35美元的目標股價。
- AtyR Pharma做什麼：AtyR Pharma Inc是一家生物治療公司，致力於通過其專有的tRNA合成酶平台發現和開發同類首創藥物。
Retractable Technologies
可伸縮技術
- The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw acquired a total of 8,788 shares at an average price of $1.09. The insider spent around $9,579 to buy those shares.
- What's Happening: On May 15, Retractable Technologies posted a decline in quarterly sales results.
- What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.
- 貿易：Retractable Technologies, Inc.（紐約證券交易所代碼：RVP）總裁兼首席執行官托馬斯·肖共收購了8,788股股票，平均價格爲1.09美元。知情人士花費了約9,579美元購買了這些股票。
- 發生了什麼：5月15日，Retractable Technologies公佈的季度銷售業績有所下降。
- Tractable Technologies的作用：Tractable Technologies Inc爲醫療保健行業設計、開發、製造和銷售安全注射器和其他安全醫療產品。
- Nasdaq, S&P 500 Record Worst Session Since 2022 Amid Tesla, Alphabet Selloff: Investor Optimism Decreases Further
- 在特斯拉和Alphabet拋售的情況下，納斯達克和標準普爾500指數創下2022年以來最差交易日：投資者樂觀情緒進一步下降